The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)
 

Ramakanth Sarabu

Hoffmann-La Roche Inc.

pRED, Pharma Research & Early Development

DTA Metabolism

United States

[email]@roche.com

Name/email consistency: high

 
 
 
 
 
 
 

Affiliations

  • Hoffmann-La Roche Inc., pRED, Pharma Research & Early Development, DTA Metabolism, United States. 2012
  • Roche Research Center, Roche, 340 Kingsland Street, Nutley, USA. 2003 - 2011
  • Hoffmann-La Roche Inc, Department of Discovery Chemistry, Roche Research Center, 340 Kingsland Street, USA. 2005
  • Roche Research Center, Hoffmann-La Roche Inc, Nutley, New Jersey 07110, USA. 2002

References

  1. Discovery of piragliatin--first glucokinase activator studied in type 2 diabetic patients. Sarabu, R., Bizzarro, F.T., Corbett, W.L., Dvorozniak, M.T., Geng, W., Grippo, J.F., Haynes, N.E., Hutchings, S., Garofalo, L., Guertin, K.R., Hilliard, D.W., Kabat, M., Kester, R.F., Ka, W., Liang, Z., Mahaney, P.E., Marcus, L., Matschinsky, F.M., Moore, D., Racha, J., Radinov, R., Ren, Y., Qi, L., Pignatello, M., Spence, C.L., Steele, T., Tengi, J., Grimsby, J. J. Med. Chem. (2012) [Pubmed]
  2. Novel glucokinase activators: a patent review (2008 - 2010). Sarabu, R., Berthel, S.J., Kester, R.F., Tilley, J.W. Expert. Opin. Ther. Pat (2011) [Pubmed]
  3. Anglo-Swedish Medicinal Chemistry - second symposium. Sarabu, R. IDrugs (2005) [Pubmed]
  4. Targeting glucokinase activation for the treatment of type 2 diabetes--a status review. Sarabu, R., Grimsby, J. Curr. Opin. Drug. Discov. Devel (2005) [Pubmed]
  5. Metabolic diseases drug discovery world summit. July 28-29, 2003, San Diego, CA, USA. Sarabu, R. Expert. Opin. Investig. Drugs (2003) [Pubmed]
  6. Oxazole- and imidazole-based Ser-Leu dipeptide mimetics in potent inhibitors of antigen presentation by MHC class II DR molecules. Sarabu, R., Bolin, D.R., Campbell, R., Cooper, J.R., Cox, D., Gaizband, D., Makofske, R., Nagy, Z., Olson, G.L. Drug. Des. Discov (2002) [Pubmed]
 
WikiGenes - Universities